Online citations, reference lists, and bibliographies.

Exploring Disease Through Metabolomics.

Nawaporn Vinayavekhin, Edwin A. Homan, Alan Saghatelian
Published 2010 · Biology, Medicine
Cite This
Download PDF
Analyze on Scholarcy
Share
Metabolomics approaches provide an analysis of changing metabolite levels in biological samples. In the past decade, technical advances have spurred the application of metabolomics in a variety of diverse research areas spanning basic, biomedical, and clinical sciences. In particular, improvements in instrumentation, data analysis software, and the development of metabolite databases have accelerated the measurement and identification of metabolites. Metabolomics approaches have been applied to a number of important problems, which include the discovery of biomarkers as well as mechanistic studies aimed at discovering metabolites or metabolic pathways that regulate cellular and physiological processes. By providing access to a portion of biomolecular space not covered by other profiling approaches (e.g., proteomics and genomics), metabolomics offers unique insights into small molecule regulation and signaling in biology. In the following review, we look at the integration of metabolomics approaches in different areas of basic and biomedical research, and try to point out the areas in which these approaches have enriched our understanding of cellular and physiological biology, especially within the context of pathways linked to disease.
This paper references
10.1016/S0076-6879(07)32007-7
The lipid maps initiative in lipidomics.
Kara Schmelzer (2007)
Meta - bolic profiling technologies for biomarker discovery in biomedicine and drug development
G. Schlotterbeck (2006)
10.1021/ac991131p
Electrostatic axially harmonic orbital trapping: a high-performance technique of mass analysis
Makarov (2000)
10.1016/j.ab.2004.04.004
Toward fingerprinting cellular lipidomes directly from biological samples by two-dimensional electrospray ionization mass spectrometry.
Xianlin Han (2004)
10.2183/pjab.54.194
Direct-coupling of FT-NMR to high performance liquid chromatography.
Noriyuki Watanabe (1978)
10.1016/j.chembiol.2006.08.008
An enzyme that regulates ether lipid signaling pathways in cancer annotated by multidimensional profiling.
Kyle Chiang (2006)
10.1177/095952879908200119
A Contribution to the Study of Alkaptonuria.
Archibald E. Sir Garrod (1899)
10.1073/pnas.0303415101
Differential metabolic networks unravel the effects of silent plant phenotypes.
Wolfram Weckwerth (2004)
10.1016/j.nbd.2009.02.019
Metabolomics tools for identifying biomarkers for neuropsychiatric diseases
M. Quiñones (2009)
10.1126/science.1173288
Dependence of Mouse Embryonic Stem Cells on Threonine Catabolism
J. Wang (2009)
10.1038/nature02866
Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity
Sung Hee Um (2004)
10.1002/mrc.1632
LC-NMR coupling technology: recent advancements and applications in natural products analysis.
Vassiliki Exarchou (2005)
10.1016/S0021-9673(00)95270-1
On-line coupling of high-performance liquid chromatography and nuclear magnetic resonance
Ernst Bayer (1979)
Mass spectrometry - basedmetabolomics , Mass Spectrom
K. Dettmer (2007)
10.1038/nature02979
Corrigendum: Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity
S. H. Um (2004)
10.1038/nature04648
Pharmaco-metabonomic phenotyping and personalized drug treatment
T. Andrew Clayton (2006)
10.1002/anie.200601789
Extending the scope of NMR spectroscopy with microcoil probes.
Frank C. Schroeder (2006)
10.1002/mas.20108
Mass spectrometry-based metabolomics.
K. Dettmer (2007)
Metabolomics and biochemical profiling in drug discovery and development.
Watkins Sm (2002)
10.1038/nchembio816
Kinetic flux profiling of nitrogen assimilation in Escherichia coli
J. Yuan (2006)
10.1073/pnas.68.10.2374
Quantitative analysis of urine vapor and breath by gas-liquid partition chromatography.
Linus Pauling (1971)
10.1021/ja809949r
Identification of an overabundant cholesterol precursor in hepatitis B virus replicating cells by untargeted lipid metabolite profiling.
Mary A. Rodgers (2009)
10.2217/14622416.7.7.1055
Metabolic profiling technologies for biomarker discovery in biomedicine and drug development.
Goetz Schlotterbeck (2006)
High-resolution microcoil H-1-NMR for mass-limited
D. L. Olson (1995)
10.1016/j.ab.2007.01.028
A comprehensive urinary metabolomic approach for identifying kidney cancerr.
Tobias Kind (2007)
10.1016/j.chroma.2006.05.019
Separation and quantitation of water soluble cellular metabolites by hydrophilic interaction chromatography-tandem mass spectrometry.
Sunil U. Bajad (2006)
10.1097/01.ftd.0000179845.53213.39
METLIN: A Metabolite Mass Spectral Database
C. A. Smith (2005)
Alkyl and alk-1-enyl ethers of glycerol in lipids from normal and neoplastic human tissues.
F. S. Snyder (1969)
10.1073/pnas.0801777105
Global metabolic responses of mice to Trypanosoma brucei brucei infection
Yulan Wang (2008)
Über den Stoff - wechsel der Carcinomzelle TheM 2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
O. Warburg (1924)
10.1126/science.270.5244.1967
High-Resolution Microcoil 1H-NMR for Mass-Limited, Nanoliter-Volume Samples
Dean L. Olson (1995)
10.1172/JCI34138
Metabolomic analysis of the cerebrospinal fluid reveals changes in phospholipase expression in the CNS of SIV-infected macaques.
W. R. Wikoff (2008)
10.1093/clinchem/20.8.961
Techniques of orthomolecular diagnosis.
Arthur B. Robinson (1974)
10.1073/pnas.0502267102
Perturbational profiling of a cell-line model of tumorigenesis by using metabolic measurements
Arvind Ramanathan (2005)
10.1021/bi0480335
Assignment of endogenous substrates to enzymes by global metabolite profiling.
A. Saghatelian (2004)
10.1016/j.cmet.2009.02.002
A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance.
Christopher B. Newgard (2009)
10.1093/nar/gkl838
LMSD: LIPID MAPS structure database
M. Sud (2007)
10.1021/ac051437y
XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification.
C. A. Smith (2006)
10.1194/jlr.M200169-JLR200
Lipid metabolome-wide effects of the PPARγ agonist rosiglitazones⃞s The online version of this article (available at http://www.jlr.org) contains an additional 4 tables. Published, JLR Papers in Press, August 16, 2002. DOI 10.1194/jlr.M200169-JLR200
Steven M. Watkins (2002)
10.1038/nrd728
Metabonomics: a platform for studying drug toxicity and gene function
Jeremy K. Nicholson (2002)
10.1038/nbt.1500
Systems-level metabolic flux profiling identifies fatty acid synthesis as a target for antiviral therapy
Joshua Munger (2008)
10.1021/np050255w
Metabolomics reviewed: a new "omics" platform technology for systems biology and implications for natural products research.
Simone J Rochfort (2005)
10.1002/anie.200603821
Differential analysis of 2D NMR spectra: new natural products from a pilot-scale fungal extract library.
Frank C. Schroeder (2007)
10.1002/chin.200703278
Extending the Scope of NMR Spectroscopy with Microcoil Probes
Frank C. Schroeder (2007)
10.1038/nature06734
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Heather R Christofk (2008)
10.1093/clinchem/44.12.2405
Use of phenylalanine-to-tyrosine ratio determined by tandem mass spectrometry to improve newborn screening for phenylketonuria of early discharge specimens collected in the first 24 hours.
Donald H. Chace (1998)
10.1002/(SICI)1097-0231(19960610)10:8<889::AID-RCM615>3.0.CO;2-F
High sensitivity collisionally-activated decomposition tandem mass spectrometry on a novel quadrupole/orthogonal-acceleration time-of-flight mass spectrometer.
Howard R. Morris (1996)
ward fingerprinting cellular lipidomes directly from biological samples by two - dimensional electrospray ionization mass spectrome
X. L. Han (2004)
10.1021/ac800795f
XCMS2: processing tandem mass spectrometry data for metabolite identification and structural characterization.
H. Benton (2008)
10.1002/mas.20023
Shotgun lipidomics: electrospray ionization mass spectrometric analysis and quantitation of cellular lipidomes directly from crude extracts of biological samples.
Xianlin Han (2005)
10.1073/pnas.0904489106
Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism
T. Andrew Clayton (2009)
10.1038/msb.2008.50
Metabolic profiling of the human response to a glucose challenge reveals distinct axes of insulin sensitivity
Oded Shaham (2008)
10.1038/nature08617
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
L. Dang (2009)
10.1002/(SICI)1097-0231(19970615)11:9<1015::AID-RCM958>3.0.CO;2-H
Rapid 'de novo' peptide sequencing by a combination of nanoelectrospray, isotopic labeling and a quadrupole/time-of-flight mass spectrometer.
A. Shevchenko (1997)
10.1146/annurev.pharmtox.48.113006.094715
Metabolomics: a global biochemical approach to drug response and disease.
R. Kaddurah-Daouk (2008)
10.1006/abio.2001.5513
Analysis of highly polar compounds of plant origin: combination of hydrophilic interaction chromatography and electrospray ion trap mass spectrometry.
Vladimir V. Tolstikov (2002)
A branched-chain amino acidrelated metabolic signature that differentiates obese and lean humans and contributes to insulin
C. B. Newgard (2009)
10.1016/j.tibtech.2004.03.007
Metabolomics by numbers: acquiring and understanding global metabolite data.
Royston Goodacre (2004)
10.1038/nature07762
Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression
Arun Sreekumar (2009)



This paper is referenced by
Multi-omics of obesity and weight change in the post-genomic era
Simone Wahl (2015)
10.1089/omi.2012.0057
Traditional Chinese medicine ZHENG and Omics convergence: a systems approach to post-genomics medicine in a global world.
Peng Wang (2013)
10.1021/acsinfecdis.8b00163
Noninvasive Urine Biomarker Lateral Flow Immunoassay for Monitoring Active Onchocerciasis
Ryan J Shirey (2018)
10.1007/s00216-017-0768-x
Two complementary reversed-phase separations for comprehensive coverage of the semipolar and nonpolar metabolome
Fuad J Naser (2017)
10.1007/s00216-018-1396-9
Balancing metabolome coverage and reproducibility for untargeted NMR-based metabolic profiling in tissue samples through mixture design methods
Hong Zheng (2018)
10.1080/01635581.2019.1632357
Glycyrrhiza glabra-Enhanced Extract and Adriamycin Antiproliferative Effect on PC-3 Prostate Cancer Cells
Katerina Gioti (2019)
10.1186/1471-2334-14-53
A metabolic biosignature of early response to anti-tuberculosis treatment
Sebabrata Mahapatra (2014)
10.1007/978-3-642-29752-6_1
Informatics-driven Infectious Disease Research
Bruno W. S. Sobral (2011)
10.3390/nu7042589
Inflammaging and Cancer: A Challenge for the Mediterranean Diet
Rita Ostan (2015)
Biotinylation and high affinity avidin capture as a strategy for LC-MS based metabolomics
Sofie Rhönnstad (2010)
10.1002/jnr.23157
Lipidome and proteome map of myelin membranes.
Gopakumar M. Gopalakrishnan (2013)
10.1038/s41598-017-08327-w
Plasma metabolomics profiling of maintenance hemodialysis based on capillary electrophoresis - time of flight mass spectrometry
Shuxin Liu (2017)
10.1021/acs.jproteome.7b00173
Serial Metabolome Changes in a Prospective Cohort of Subjects with Influenza Viral Infection and Comparison with Dengue Fever.
Liang Cui (2017)
10.1371/journal.pone.0125209
A Metabolomic Study of Rats with Doxorubicin-Induced Cardiomyopathy and Shengmai Injection Treatment
Yu Chen (2015)
10.1183/09031936.00122411
Exhaled breath profiling in diagnosing wheezy preschool children
Kim D. G. van de Kant (2013)
10.1016/B978-0-12-394383-5.00013-8
Urinary metabolomics in newborns and infants.
Vassilios Fanos (2012)
10.5355/JAST.2011.A173
HPLC-MS-Based Metabonomics Reveals Disordered Lipid Metabolism in Patients with Metabolic Syndrome
Shili Chen (2011)
Studies on Distribution and Persistence of Halquinol and its Metabolites in Various Tissues of Chicken
Indu Thripathi (2013)
Development of nanoflow liquid chromatography-nanoelectrospray ionization mass spectrometry methodology for improved urine metabolomics
Andrew J Chetwynd (2015)
10.1007/978-1-4939-9438-0_4
Chiral Metabolomics Using Triazine-Based Chiral Labeling Reagents by UPLC-ESI-MS/MS.
Toshimasa Toyo’oka (2019)
10.1038/nrc2901
Activity-based protein profiling for biochemical pathway discovery in cancer
Daniel K. Nomura (2010)
10.5772/30888
Functional Proteomics: Mapping Lipid-Protein Interactomes
Clive S. D’Santos (2012)
10.1002/rcm.5072
Metabolomic investigation of cholestasis in a rat model using ultra-performance liquid chromatography/tandem mass spectrometry.
Masayo Aoki (2011)
10.1155/2014/542549
Differential Effects of Dry Eye Disorders on Metabolomic Profile by 1H Nuclear Magnetic Resonance Spectroscopy
Carmen Galbis-Estrada (2014)
10.1016/j.jinsphys.2012.07.010
Gas chromatography-mass spectrometry metabolite profiling of worker honey bee (Apis mellifera L.) hemolymph for the study of Nosema ceranae infection.
Konstantinos A. Aliferis (2012)
10.1371/journal.pntd.0004449
Metabolomics-Based Discovery of Small Molecule Biomarkers in Serum Associated with Dengue Virus Infections and Disease Outcomes
Natalia V Voge (2016)
10.1038/nprot.2016.040
A LC-MS–based workflow for measurement of branched fatty acid esters of hydroxy fatty acids
Tejia Zhang (2016)
10.1039/c4an00296b
The use of EEM fluorescence data and OPLS/UPLS-DA algorithm to discriminate between normal and cancer cell lines: a feasibility study.
Ana Carolina de Oliveira Neves (2014)
Metabolomics analyses to better understand complex phenotypes
Zhonghao Yu (2013)
10.1016/j.jpsychires.2012.08.015
Comparison of metabolic profiles of acutely ill and short-term weight recovered patients with anorexia nervosa reveals alterations of 33 out of 163 metabolites.
Manuel Föcker (2012)
10.1002/rcm.6960
A comprehensive high-resolution mass spectrometry approach for characterization of metabolites by combination of ambient ionization, chromatography and imaging methods.
A. Berisha (2014)
10.1073/pnas.1221969110
Onchocerca volvulus-neurotransmitter tyramine is a biomarker for river blindness
Daniel Globisch (2013)
See more
Semantic Scholar Logo Some data provided by SemanticScholar